{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:56:23Z","timestamp":1781340983757,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03286-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:59:37Z","timestamp":1776671977000},"page":"864-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry"],"prefix":"10.1007","volume":"59","author":[{"given":"Andrea","family":"Rubboli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1901-0703","authenticated-orcid":false,"given":"Graziella","family":"Pompei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Colletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Porretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciahbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"3286_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van \u2018t Hof AW, ten Berg JM, WOEST study investigators (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107\u20131115. https:\/\/doi.org\/10.1016\/S0140-6736(12)62177-1","journal-title":"Lancet"},{"key":"3286_CR2","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","volume":"375","author":"CM Gibson","year":"2016","unstructured":"Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, Korjian S, Daaboul Y, Lip GY, Cohen M, Husted S, Peterson ED, Fox KA (2016) Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med 375:2423\u20132434. https:\/\/doi.org\/10.1056\/NEJMoa1611594","journal-title":"N Engl J Med"},{"key":"3286_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","volume":"377","author":"CP Cannon","year":"2017","unstructured":"Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH, RE-DUAL PCI Steering Committee and Investigators (2017) Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med 377:1513\u20131524. https:\/\/doi.org\/10.1056\/NEJMoa1708454","journal-title":"N Engl J Med"},{"key":"3286_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","volume":"380","author":"RD Lopes","year":"2019","unstructured":"Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH, AUGUSTUS Investigators (2019) Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med 380:1509\u20131524. https:\/\/doi.org\/10.1056\/NEJMoa1817083Epub 2019 Mar 17. PMID: 30883055","journal-title":"N Engl J Med"},{"issue":"10206","key":"3286_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","volume":"394","author":"P Vranckx","year":"2019","unstructured":"Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A (2019) Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 394(10206):1335\u20131343. https:\/\/doi.org\/10.1016\/S0140-6736(19)31872-0","journal-title":"Lancet"},{"key":"3286_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"DJ Kumbhani","year":"2021","unstructured":"Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, Marine JE, Mehran R, Messe SR, Patel NS, Peterson BE, Rosenfield K, Spinler SA, Thourani VH (2021) 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 77:629\u2013658. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.011","journal-title":"J Am Coll Cardiol"},{"key":"3286_CR7","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, L\u00f8chen ML, Lumbers RT, Maesen B, M\u00f8lgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D, ESC Scientific Document Group (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45:3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"3286_CR8","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","volume":"46","author":"F Praz","year":"2025","unstructured":"Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, Ajmone Marsan N, Barili F, Bonaros N, Cosyns B, De Paulis R, Gamra H, Jahangiri M, Jeppsson A, Klautz RJM, Mores B, P\u00e9rez-David E, P\u00f6ss J, Prendergast BD, Rocca B, Rossello X, Suzuki M, Thiele H, Tribouilloy CM, Wojakowski W, ESC\/EACTS Scientific Document Group (2025) 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 46:4635\u20134736. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf194","journal-title":"Eur Heart J"},{"key":"3286_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1160\/TH09-06-0418","volume":"103","author":"F Sofi","year":"2010","unstructured":"Sofi F, Marcucci R, Gori AM, Giusti B, Abbate R, Gensini GF (2010) Clopidogrel non-responsiveness and risk of cardiovascular morbidity. updated meta-analysis Thromb Haemost 103:841\u2013848. https:\/\/doi.org\/10.1160\/TH09-06-0418","journal-title":"updated meta-analysis Thromb Haemost"},{"key":"3286_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.cir.0000047060.60595.cc","volume":"107","author":"WC Lau","year":"2003","unstructured":"Lau WC, Waskell LA, Watkins PB, Neer CJ, Horowitz K, Hopp AS, Tait AR, Carville DG, Guyer KE, Bates ER (2003) Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 107:32\u201337. https:\/\/doi.org\/10.1161\/01.cir.0000047060.60595.cc","journal-title":"Circulation"},{"key":"3286_CR11","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.3390\/jcm14176331","volume":"14","author":"L Martini","year":"2025","unstructured":"Martini L, Lisi M, Pompei G, Arioti M, Bendandi F, Henein MY, Cameli M, Rubboli A (2025) Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How. J Clin Med 14:6331. https:\/\/doi.org\/10.3390\/jcm14176331","journal-title":"J Clin Med"},{"key":"3286_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim HK, Tantry US, Smith SC Jr, Jeong MH, Park SJ, Kim MH, Lim DS, Shin ES, Park DW, Huo Y, Chen SL, Bo Z, Goto S, Kimura T, Yasuda S, Chen WJ, Chan M, Aradi D, Geisler T, Gorog DA, Sibbing D, Lip GYH, Angiolillo DJ, Gurbel PA, Jeong YH (2021) The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. Thromb Haemost 121:422\u2013432. https:\/\/doi.org\/10.1055\/s-0040-1718729","journal-title":"Thromb Haemost"},{"key":"3286_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/ehjcvp\/pvaf043","volume":"11","author":"S Kim","year":"2025","unstructured":"Kim S, Park S, Kim H, Aung N, Kim SH, Chang K, Choi Y (2025) Clinical outcomes with the use of aspirin vs. clopidogrel as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation. Eur Heart J Cardiovasc Pharmacother 11:532\u2013539. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf043","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3286_CR14","doi-asserted-by":"publisher","first-page":"e015495","DOI":"10.1161\/CIRCINTERVENTIONS.125.015495","volume":"18","author":"M Natsuaki","year":"2025","unstructured":"Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T (2025) Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation. Circ Cardiovasc Interv 18:e015495. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.125.015495","journal-title":"Circ Cardiovasc Interv"},{"key":"3286_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2459\/JCM.0000000000001372","volume":"23","author":"A Sciahbasi","year":"2022","unstructured":"Sciahbasi A, Gargiulo G, Talarico GP, Cesaro A, Zilio F, De Rosa S, Talanas G, Tebaldi M, And\u00f2 G, Rigattieri S, Misuraca L, Cortese B, Imperadore F, Lucci V, Guiducci V, Renda G, Zezza L, Versaci F, Giannico MB, Caruso M, Spaccarotella C, Calabr\u00f2 P, Esposito G, Tarantini G, Musumeci G, Rubboli A (2022) Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent. J Cardiovasc Med (Hagerstown) 23:738\u2013743. https:\/\/doi.org\/10.2459\/JCM.0000000000001372","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"17","key":"3286_CR16","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE van Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344\u20132351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.685313","journal-title":"Circulation"},{"key":"3286_CR17","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736\u20132747. 10.1161 CIRCULATIONAHA.110.009449","journal-title":"Circulation"},{"key":"3286_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/FJC.0000000000001607","volume":"84","author":"A Sciahbasi","year":"2024","unstructured":"Sciahbasi A, De Rosa S, Gargiulo G, Giacoppo D, Calabr\u00f2 P, Talarico GP, Zilio F, Talanas G, Tebaldi M, And\u00f2 G, Rigattieri S, Misuraca L, Cortese B, Musuraca G, Lucci V, Guiducci V, Renda G, Zezza L, Versaci F, Giannico MB, Caruso M, Fischetti D, Colletta M, Santarelli A, Larosa C, Iannone A, Esposito G, Tarantini G, Musumeci G, Rubboli A (2024) Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry. J Cardiovasc Pharmacol 84:457\u2013467. https:\/\/doi.org\/10.1097\/FJC.0000000000001607","journal-title":"J Cardiovasc Pharmacol"},{"key":"3286_CR19","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","volume":"397","author":"BK Koo","year":"2021","unstructured":"Koo BK, Kang J, Park KW, Rhee TM, Yang HM, Won KB, Rha SW, Bae JW, Lee NH, Hur SH, Yoon J, Park TH, Kim BS, Lim SW, Cho YH, Jeon DW, Kim SH, Han JK, Shin ES, Kim HS, HOST-EXAM investigators (2021) Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet 397:2487\u20132496. https:\/\/doi.org\/10.1016\/S0140-6736(21)01063-1","journal-title":"Lancet"},{"key":"3286_CR20","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(25)00449-0","volume":"405","author":"KH Choi","year":"2025","unstructured":"Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY, SMART-CHOICE 3 investigators (2025) Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. Lancet 405:1252\u20131263. https:\/\/doi.org\/10.1016\/S0140-6736(25)00449-0","journal-title":"Lancet"},{"key":"3286_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.carrev.2025.06.006","volume":"80","author":"SA Wani","year":"2025","unstructured":"Wani SA, Naveed MA, Azeem B, Ashraf S, Ali A, Ali T, Fatima F, Shah M, Neppala S, Ahmed R (2025) Comparative outcomes of clopidogrel vs aspirin monotherapy in post-PCI patients: An updated systematic review and meta-analysis. Cardiovasc Revasc Med 80:122\u2013130. https:\/\/doi.org\/10.1016\/j.carrev.2025.06.006","journal-title":"Cardiovasc Revasc Med"},{"key":"3286_CR22","doi-asserted-by":"publisher","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, ESC Scientific Document Group (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 45(36):3415\u20133537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177. PMID: 39210710","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"3286_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0140-6736(25)01562-4","volume":"406","author":"M Valgimigli","year":"2025","unstructured":"Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H, Kim HS, Kang J, Park KW, Pettersen A\u00c5, Woodward M, Bhatt DL, Calabr\u00f2 P, Angiolillo DJ, Mehran R, Song YB, Hahn JY (2025) Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. Lancet 406:1091\u20131102. 10.1016S0140-6736(25)01562-4","journal-title":"Lancet"},{"key":"3286_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI20986","volume":"113","author":"RT Dorsam","year":"2004","unstructured":"Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113:340\u2013345. https:\/\/doi.org\/10.1172\/JCI20986","journal-title":"J Clin Invest"},{"issue":"3","key":"3286_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jacc.2004.04.047","volume":"44","author":"PC Lee","year":"2004","unstructured":"Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK (2004) Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44(3):541\u2013546. https:\/\/doi.org\/10.1016\/j.jacc.2004.04.047","journal-title":"J Am Coll Cardiol"},{"key":"3286_CR26","doi-asserted-by":"publisher","first-page":"1287434","DOI":"10.3389\/fcvm.2023.1287434","volume":"10","author":"W Deng","year":"2024","unstructured":"Deng W, Wang D, Wan Y, Lai S, Ding Y, Wang X (2024) Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review. Front Cardiovasc Med 10:1287434. https:\/\/doi.org\/10.3389\/fcvm.2023.1287434","journal-title":"Front Cardiovasc Med"},{"key":"3286_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.thromres.2014.01.007","volume":"133","author":"MK Puurunen","year":"2014","unstructured":"Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemel\u00e4 M, Lip GY, Airaksinen KE (2014) CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Thromb Res 133:560\u2013566. https:\/\/doi.org\/10.1016\/j.thromres.2014.01.007","journal-title":"Thromb Res"},{"key":"3286_CR28","doi-asserted-by":"publisher","first-page":"e004700","DOI":"10.1136\/bmjopen-2013-004700","volume":"4","author":"M Puurunen","year":"2014","unstructured":"Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GY, Airaksinen JK (2014) Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ Open 4:e004700. https:\/\/doi.org\/10.1136\/bmjopen-2013-004700","journal-title":"BMJ Open"},{"key":"3286_CR29","doi-asserted-by":"publisher","first-page":"e0128492","DOI":"10.1371\/journal.pone.0128492","volume":"10","author":"HM Lahtela","year":"2015","unstructured":"Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, Rubboli A, Ylitalo A, Valencia J, Lip GY, Airaksinen KE (2015) Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLoS ONE 10:e0128492. https:\/\/doi.org\/10.1371\/journal.pone.0128492","journal-title":"PLoS ONE"},{"key":"3286_CR30","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/clc.22821","volume":"40","author":"HM Lahtela","year":"2017","unstructured":"Lahtela HM, Bah A, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Karjalainen PP, Proietti M, Hartikainen JEK, Lip GYH, Airaksinen KEJ (2017) Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. Clin Cardiol 40:1264\u20131270. https:\/\/doi.org\/10.1002\/clc.22821","journal-title":"Clin Cardiol"},{"issue":"9921","key":"3286_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"3286_CR32","doi-asserted-by":"publisher","unstructured":"Nishikura T, Yamamoto K, Wakabayashi K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Onishi Y, Hibi K, Kawai K, Murakami T, Takasaki A, Higashitani N, Nakano M, Ono K, Kimura T, STOPDAPT-3 investigators (2025) Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy. JACC Asia Nov 13:S2772-3747(25)00542-3. https:\/\/doi.org\/10.1016\/j.jacasi.2025.09.015","DOI":"10.1016\/j.jacasi.2025.09.015"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03286-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03286-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03286-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:40Z","timestamp":1781339560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03286-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3286"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03286-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8574706\/v1","asserted-by":"object"}]},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}